Biointron Biological has launched RushData, a new platform to support the process of antibody discovery for pharmaceutical and biotechnology companies employing AI and ML.

View CAMP4 Therapeutics Corporation CAMP stock quote prices, financial information, real-time forecasts, and company news from CNN.

Biointron has launched RushData, a platform integrating 1-day CHO expression with antibody assays for structured, AI-ready data delivery.

This infographic explores the key multiomics fields, their integration across research applications, and real-world case ...

Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...

The intersection of trace metals and peptide biochemistry has opened a compelling frontier in laboratory research. The post ...

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine ...

Congenital heart disease (CHD) is the most common congenital anomaly, with lifelong implications as survival into adulthood becomes the norm. Despite advances in prenatal detection, surgical care and ...

A cutting-edge mini-review published in the inaugural issue of Targetome elaborates on the value of proteome-wide dose-response measurements as a ...

A new study reveals 8-chloroadenosine inhibits hepatocellular carcinoma by disrupting the ADAR1/PPARγ lipid metabolism axis.

RushData is a newly launched platform that accelerates antibody data generation from weeks to days through 1-day CHO expression and high-throughput, parallel processing of 3,000+ molecules per batch, ...